What labs should be checked for a patient suspected of having hypophosphatemia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 25, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Laboratory Evaluation for Hypophosphatemia

When evaluating a patient with suspected hypophosphatemia, obtain serum phosphate, calcium, alkaline phosphatase, parathyroid hormone, 25(OH) vitamin D, 1,25(OH)₂ vitamin D, and creatinine, along with spot urine for phosphate, calcium, and creatinine to calculate TmP/GFR and urinary calcium:creatinine ratio. 1

Essential Serum Tests

The core biochemical panel should include:

  • Serum phosphate - Confirms hypophosphatemia (defined as <2.5 mg/dL or 0.8 mmol/L), using age-related reference ranges 1, 2
  • Serum calcium - Critical for categorizing the etiology: elevated suggests primary hyperparathyroidism, low suggests secondary hyperparathyroidism or vitamin D deficiency, and normal suggests primary renal phosphate wasting 1, 2
  • Alkaline phosphatase (ALP) - Elevated levels indicate active rickets in children or osteomalacia in adults; bone-specific ALP is preferred in adults 1
  • Parathyroid hormone (PTH) - Helps differentiate PTH-mediated from non-PTH-mediated causes; levels are typically at upper normal range or slightly elevated in X-linked hypophosphatemia 1
  • 25(OH) vitamin D - Essential to exclude vitamin D deficiency as a cause 1
  • 1,25(OH)₂ vitamin D - Typically low or inappropriately normal in the setting of hypophosphatemia due to renal phosphate wasting 1
  • Creatinine - Assesses renal function and is needed for TmP/GFR calculation 1

Essential Urine Tests

A spot urine sample should be obtained for:

  • Urinary phosphate, calcium, and creatinine - Required to calculate tubular maximum reabsorption of phosphate per glomerular filtration rate (TmP/GFR) and urinary calcium:creatinine ratio 1
  • TmP/GFR calculation - Fractional phosphate excretion >15% in the presence of hypophosphatemia confirms renal phosphate wasting 1, 2

Important caveat: In patients with insufficient phosphate intake or impaired intestinal absorption (suspected by low urinary phosphate levels), TmP/GFR can be falsely low until serum phosphate is restored to normal 1

Additional Tests to Exclude Fanconi Syndrome

To rule out non-selective renal tubular phosphate wasting (Fanconi syndrome), evaluate urine for:

  • Bicarbonate, amino acids, glucose, and uric acid losses 1
  • Low molecular mass proteinuria 1

Advanced Diagnostic Tests

When initial workup suggests hereditary hypophosphatemic disorders:

  • Intact FGF23 levels - Elevated in FGF23-mediated hypophosphatemia (including X-linked hypophosphatemia and tumor-induced osteomalacia); however, normal levels do not exclude disease but should be interpreted as inappropriately normal in the setting of hypophosphatemia 1, 3
    • FGF23 is most informative in untreated patients, as levels are influenced by phosphate intake and vitamin D therapy 1
    • Normal range varies considerably by assay used 1
  • Genetic testing - PHEX gene analysis confirms X-linked hypophosphatemia when feasible 1

Practical Approach Algorithm

  1. Confirm hypophosphatemia with serum phosphate and calculate TmP/GFR from spot urine 1, 2
  2. If TmP/GFR >15%: Renal phosphate wasting is confirmed - proceed to step 3 2
  3. Check serum calcium to categorize:
    • High calcium → Primary hyperparathyroidism 2
    • Low calcium → Secondary hyperparathyroidism or vitamin D deficiency 2
    • Normal calcium → Primary renal phosphate wasting (consider FGF23 measurement) 2
  4. Measure ALP and bone-specific ALP to assess for active bone disease 1, 3
  5. Screen for Fanconi syndrome if multiple tubular defects suspected 1
  6. Consider FGF23 and genetic testing in chronic cases with appropriate clinical features 1, 3

Common Pitfalls

  • Age-related reference ranges: Serum phosphate levels in infants may be normal within the first 3-4 months of life despite underlying disease 1
  • Timing of FGF23 measurement: Should be obtained before initiating phosphate or vitamin D therapy for most accurate interpretation 1
  • Medication review: Always obtain thorough medication history, as glucose administration, antacids, diuretics, and steroids are common precipitants 4

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

The pathophysiology of hypophosphatemia.

Best practice & research. Clinical endocrinology & metabolism, 2024

Research

Severe hypophosphatemia in hospitalized patients.

Archives of internal medicine, 1988

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.